Due to health issues, this site is no longer maintained and will be shut down shortly.

CG:603718 Shanghai Hile Bio-Technology Co., Ltd

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers porcine parvovirus oil emulsion inactivated vaccines, Pseudorabies live vaccines, Streptococcus suis disease inactivated vaccines, Trivalent live vaccines, swine blast vaccines, porcine reproductive and respiratory syndrome vaccines, Piglet Escherichia coli K88/K99 Bivalent gene engineering inactivated vaccines, swine atrophic rhinitis inactivated vaccines, pig infectious gastroenteritis and porcine epidemic diarrhea inactivated vaccines, porcine circovirus type 2 inactivated vaccines, and porcine encephalitis live vaccines. It also provides newcastle disease low virulent live vaccines; newcastle disease, infectious bronchitis, and Avian Influenza triple inactivated vaccines; newcastle disease, infectious bronchitis, and egg drop syndrome triple inactivated oil emulsion vaccines; avian infectious bronchitis live vaccines; newcastle disease and avian infectious bronchitis combined living vaccines; newcastle disease inactivated vaccines; newcastle disease low virulent live vaccines; chicken Marek's disease turkey herpes virus live vaccines; chicken pox live vaccines; duck plague live vaccines; chicken newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; newcastle disease and Avian Influenza inactivated vaccines; chicken infectious rhinitis inactivated vaccines; chicken infectious bursal disease live vaccines; and chicken infectious rhinitis and newcastle disease inactivated vaccines, as well as various other live and inactivated vaccines. The company was founded in 1981 and is based in Shanghai, China. Shanghai Hile Bio-Technology Co., Ltd. is a subsidiary of Shanghai Haoyuan Science And Technology Development Co., Ltd.

11.31 CNY
As of 03/24/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Index country:  China
Country of incorporation:  China
IPO date:  05/15/2015
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   0 CNY
Current dividend yield:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy